Go Pro

Best Biotechnology Stocks

Biotech stocks open the door to investing in innovation that’s shaping the future of healthcare. From pioneering drug developers to specialized firms in genetic engineering and diagnostics, this sector offers exposure to breakthroughs with the potential for transformative impact—and strong returns. These stocks are known for their potential for high growth but also come with significant volatility due to the complex nature of biotechnological development and regulatory environments.

The list below highlights some of the most widely followed biotech stocks in today’s market. It features a range of companies—from established leaders with approved therapies to up-and-coming firms advancing promising clinical pipelines. View each stock's current price, PE ratio, volume, and recent indicators of potential movement.

MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceP/E RatioMarket CapVolumeAverage VolumeIndicator(s)
AbbVie Inc. stock logo
ABBV
AbbVie
$251.07
-0.2%
123.68$444.60 billion6.98 million8.57 million
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$513.53
+2.4%
28.23$186.32 billion2.22 million2.16 million
Danaher Corporation stock logo
DHR
Danaher
$193.81
+1.7%
37.49$134.82 billion4.52 million4.11 million
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$498.01
+0.3%
29.54$126.07 billion1.44 million1.80 million
GSK PLC Sponsored ADR stock logo
GSK
GSK
$51.36
-2.0%
13.35$106.16 billion3.20 million3.93 million
Bloom Energy Corporation stock logo
BE
Bloom Energy
$289.17
-4.5%
N/A$86.10 billion16.28 million13.38 million
Lumentum Holdings Inc. stock logo
LITE
Lumentum
$801.16
-6.6%
148.36$66.76 billion4.12 million5.62 million
argenex SE stock logo
ARGX
argenex
$909.50
-2.0%
40.49$57.70 billion370,077394,869
Cencora, Inc. stock logo
COR
Cencora
$288.20
+1.8%
22.10$55.06 billion1.28 million1.49 million
Takeda Pharmaceutical Co. stock logo
TAK
Takeda Pharmaceutical
$15.96
-0.5%
40.91$51.02 billion2.17 million2.85 million
Do NOT Buy SpaceX – Do This Instead (Ad)

SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel

Read Tilson's free analysis and find out what to do with your money
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$301.67
+0.2%
82.42$40.19 billion1.07 million1.22 million
Royalty Pharma PLC stock logo
RPRX
Royalty Pharma
$55.78
-0.5%
37.95$32.29 billion2.52 million3.77 million
IQVIA Holdings Inc. stock logo
IQV
IQVIA
$203.33
+5.2%
25.20$32.25 billion2.48 million1.55 million
Veeva Systems Inc. stock logo
VEEV
Veeva Systems
$184.45
+3.9%
32.88$28.83 billion3.15 million2.68 million
Moderna, Inc. stock logo
MRNA
Moderna
$72.50
+3.5%
N/A$27.79 billion9.23 million8.41 million
Illumina, Inc. stock logo
ILMN
Illumina
$183.89
+4.6%
33.43$26.60 billion2.13 million1.96 million
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
$93.92
+0.9%
N/A$23.53 billion545,347977,216
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$547.15
+1.0%
20.20$23.00 billion413,265566,608
International Flavors & Fragrances Inc. stock logo
IFF
International Flavors & Fragrances
$81.21
+2.5%
24.83$20.23 billion2.23 million1.93 million
Fabrinet stock logo
FN
Fabrinet
$548.16
-2.5%
47.09$20.14 billion684,1741.12 million
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$41.07
+6.0%
8.93$18.35 billion12.06 million13.59 million
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$543.57
+2.6%
34.17$15.12 billion312,635294,025
Icon Plc stock logo
ICLR
Icon
$175.05
+0.8%
31.15$13.30 billion809,2361.12 million
Revvity Inc. stock logo
RVTY
Revvity
$112.80
+1.4%
53.97$12.41 billion1.42 million1.44 million
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$371.58
0.0%
49.68$10.96 billion296,687378,572
Charles River Laboratories International, Inc. stock logo
CRL
Charles River Laboratories International
$229.13
+1.0%
N/A$10.92 billion1.09 million803,776
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$132.56
-0.5%
N/A$10.63 billion4.79 million2.75 million
Suzano S.A. Sponsored ADR stock logo
SUZ
Suzano
$7.81
+0.6%
4.65$9.62 billion4.17 million3.16 million
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$9.20
+5.0%
N/A$9.17 billion16.30 million12.26 million
iShares Biotechnology ETF stock logo
IBB
iShares Biotechnology ETF
$190.12
0.0%
N/A$9.08 billion1.65 million1.50 million
TG Therapeutics, Inc. stock logo
TGTX
TG Therapeutics
$53.52
-2.6%
18.71$8.41 billion2.01 million3.08 million
Vaxcyte, Inc. stock logo
PCVX
Vaxcyte
$56.08
-3.5%
N/A$8.39 billion1.49 million1.90 million
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
$132.77
+0.0%
N/A$8.22 billion3.60 million5.67 million
Bio-Rad Laboratories, Inc. stock logo
BIO.B
Bio-Rad Laboratories
$296.49
48.85$7.93 billion1062
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$88.89
+0.1%
N/A$7.81 billion1.68 million1.80 million
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$38.48
-0.6%
N/A$6.61 billion2.42 million3.07 million
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
$102.25
-0.6%
N/A$6.41 billion1.50 million2.20 million
Oruka Therapeutics, Inc. stock logo
ORKA
Oruka Therapeutics
$93.29
-2.0%
N/A$5.74 billion1.48 million1.61 million
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
$29.89
+3.5%
N/A$5.36 billion1.62 million2.75 million
Dianthus Therapeutics, Inc. stock logo
DNTH
Dianthus Therapeutics
$90.21
-7.5%
N/A$5.33 billion1.61 million1.49 million
The end may be near for these iconic stocks (Ad)

Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel

Watch Marc Chaikin's free presentation and get his full buy-and-sell list today
Celcuity, Inc. stock logo
CELC
Celcuity
$104.49
-0.1%
N/A$5.10 billion1.10 million1.65 million
10x Genomics stock logo
TXG
10x Genomics
$39.05
+1.9%
N/A$4.87 billion3.26 million3.49 million
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
$28.73
-8.1%
N/A$4.52 billion4.36 million6.50 million
Tutor Perini Corporation stock logo
TPC
Tutor Perini
$79.84
-3.8%
54.31$4.37 billion673,871550,941
Standex International Corporation stock logo
SXI
Standex International
$349.22
-2.4%
42.54$4.33 billion257,852221,613
JPMorgan U.S. Tech Leaders ETF stock logo
JTEK
JPMorgan U.S. Tech Leaders ETF
$108.32
-2.9%
47.07$4.27 billion194,616303,819
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$25.98
+1.0%
N/A$4.08 billion1.20 million2.01 million
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$21.79
-1.9%
N/A$3.67 billion1.38 million2.14 million
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$33.48
-2.4%
N/A$3.53 billion2.17 million2.32 million
Adaptive Biotechnologies Corporation stock logo
ADPT
Adaptive Biotechnologies
$22.37
+4.3%
N/A$3.43 billion3.28 million3.94 million
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
$42.66
-0.6%
N/A$3.08 billion1.07 million1.68 million
Hercules Capital, Inc. stock logo
HTGC
Hercules Capital
$15.94
+1.0%
9.00$2.95 billion1.22 million1.24 million
Redwire Corporation stock logo
RDW
Redwire
$11.96
-2.2%
N/A$2.92 billion21.83 million40.95 million
Kailera Therapeutics, Inc. stock logo
KLRA
Kailera Therapeutics
$20.82
-5.5%
N/A$2.70 billion1.35 million841,431
BioCryst Pharmaceuticals, Inc. stock logo
BCRX
BioCryst Pharmaceuticals
$9.65
-3.5%
N/A$2.54 billion4.87 million5.72 million
Immunome, Inc. stock logo
IMNM
Immunome
$21.49
+1.4%
N/A$2.40 billion2.03 million1.64 million
Diversified Healthcare Trust stock logo
DHC
Diversified Healthcare Trust
$9.24
-0.6%
N/A$2.25 billion1.23 million2.11 million
Generate Biomedicines Inc stock logo
GENB
Generate Biomedicines
$16.50
-2.2%
N/A$2.12 billion964,430701,241
Monte Rosa Therapeutics, Inc. stock logo
GLUE
Monte Rosa Therapeutics
$24.02
-0.7%
N/A$2.04 billion1.37 million1.59 million
AnaptysBio, Inc. stock logo
ANAB
AnaptysBio
$65.43
-3.1%
N/A$2.00 billion698,054552,269
Amylyx Pharmaceuticals, Inc. stock logo
AMLX
Amylyx Pharmaceuticals
$17.95
-0.1%
N/A$2.00 billion1.76 million1.82 million
Rapport Therapeutics, Inc. stock logo
RAPP
Rapport Therapeutics
$39.39
-5.5%
N/A$1.99 billion303,922394,962
Lakefront Biotherapeutics American Depositary Shares stock logo
LKFT
Lakefront Biotherapeutics American Depositary Shares
$29.60
-1.3%
N/A$1.98 billion293,721174,219
Anbio Biotechnology stock logo
NNNN
Anbio Biotechnology
$12.35
-9.9%
N/A$1.97 billion34,80450,268
Recursion Pharmaceuticals, Inc. stock logo
RXRX
Recursion Pharmaceuticals
$3.67
N/A$1.94 billion35.68 million20.06 million
Zymeworks Inc. stock logo
ZYME
Zymeworks
$25.72
-1.6%
N/A$1.91 billion535,290665,268
Nanobiotix S.A. - Sponsored ADR stock logo
NBTX
Nanobiotix
$39.48
+4.7%
N/A$1.91 billion77,27074,760
Tyra Biosciences, Inc. stock logo
TYRA
Tyra Biosciences
$29.41
-7.9%
N/A$1.90 billion752,0341.15 million
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
$18.48
+0.6%
N/A$1.89 billion3.27 million2.22 million
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$3.97
-4.6%
N/A$1.86 billion21.37 million13.07 million
Urogen Pharma stock logo
URGN
Urogen Pharma
$37.94
+3.1%
N/A$1.79 billion1.13 million612,714
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$9.56
-6.2%
N/A$1.72 billion1.91 million2.31 million
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
$32.50
-11.5%
N/A$1.72 billion228,772264,360
Fortrea Holdings Inc. stock logo
FTRE
Fortrea
$17.58
+1.0%
N/A$1.65 billion1.57 million1.50 million
Ascentage Pharma Group International - Unsponsored ADR stock logo
AAPG
Ascentage Pharma Group International
$17.96
+2.3%
N/A$1.64 billion14,85518,941
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
$31.65
-0.3%
N/A$1.61 billion828,841529,410
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
$27.09
+4.2%
N/A$1.60 billion580,921876,945
Novavax, Inc. stock logo
NVAX
Novavax
$9.46
+0.4%
N/A$1.55 billion4.57 million4.35 million
Septerna, Inc. stock logo
SEPN
Septerna
$34.61
+3.3%
N/A$1.51 billion440,358444,900
Capricor Therapeutics, Inc. stock logo
CAPR
Capricor Therapeutics
$23.07
-4.2%
N/A$1.39 billion1.81 million1.40 million
abrdn Healthcare Investors stock logo
HQH
abrdn Healthcare Investors
$21.75
-1.1%
N/A$1.26 billion240,038176,881
Azenta, Inc. stock logo
AZTA
Azenta
$26.19
+2.6%
N/A$1.18 billion641,910808,412
WAVE Life Sciences Ltd. stock logo
WVE
WAVE Life Sciences
$5.84
+0.5%
N/A$1.12 billion3.15 million3.27 million
Oaktree Specialty Lending Corp. stock logo
OCSL
Oaktree Specialty Lending
$12.15
+1.8%
21.32$1.05 billion652,721555,437
Evotec AG stock logo
EVO
Evotec
$2.85
+1.8%
N/A$996.12 million35,47835,306
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$17.29
-6.4%
N/A$971.41 million1.85 million2.08 million
Sana Biotechnology, Inc. stock logo
SANA
Sana Biotechnology
$3.56
+2.0%
N/A$971.24 million2.88 million3.85 million
Replimune Group, Inc. stock logo
REPL
Replimune Group
$11.22
+1.4%
N/A$929.27 million2.98 million3.68 million
ODDITY Tech Ltd. stock logo
ODD
ODDITY Tech
$17.01
+12.4%
21.53$871.11 million1.82 million1.90 million
Transcat, Inc. stock logo
TRNS
Transcat
$92.71
-0.1%
159.85$866.54 million214,436185,449
They proved it worked in '76. Then buried it. (Ad)

In 1976, Chevron, Unocal, and Texaco each confirmed the same energy technology worked - no fuel costs, no carbon, no supply chain. All three killed their projects because it threatened their core business. Now one company has spent sixty years developing what Big Oil refused to touch. Google just signed a 15-year contract, Bill Gates wrote a $100 million check, and on July 4th the government hands it a competitive edge no other energy source receives.tc pixel

See the company that spent 60 years perfecting what Big Oil buried
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$13.29
+1.9%
N/A$746.71 million1.91 million1.53 million
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
$6.73
-5.2%
N/A$734.04 million680,108626,952
Relmada Therapeutics, Inc. stock logo
RLMD
Relmada Therapeutics
$6.39
-7.7%
N/A$725.84 million2.14 million2.39 million
Rigel Pharmaceuticals, Inc. stock logo
RIGL
Rigel Pharmaceuticals
$38.29
-2.1%
2.05$723.80 million243,485361,268
4D Molecular Therapeutics, Inc. stock logo
FDMT
4D Molecular Therapeutics
$12.69
-4.6%
N/A$695.27 million1.07 million1.08 million
Bright Minds Biosciences Inc. stock logo
DRUG
Bright Minds Biosciences
$66.54
-5.2%
N/A$683.20 million576,303428,256
SLR Investment Corp. stock logo
SLRC
SLR Investment
$12.45
+0.6%
7.59$674.84 million387,954348,831
Prime Medicine, Inc. stock logo
PRME
Prime Medicine
$3.89
+5.4%
N/A$666.48 million3.79 million3.24 million
Ginkgo Bioworks Holdings, Inc. stock logo
DNA
Ginkgo Bioworks
$10.27
+3.6%
N/A$647.37 million1.72 million1.26 million
Phreesia, Inc. stock logo
PHR
Phreesia
$10.74
+4.3%
71.57$636.04 million902,9841.19 million

Frequently Asked Questions

Biotech stocks represent shares of companies in the biotechnology sector, which focuses on using biological processes, organisms, or systems to develop products that improve health, fight diseases, and benefit the environment. This sector includes companies that work on drug development, genetic research, biologically derived materials, and more. Due to the innovative and often breakthrough nature of their work, biotech stocks are known for their volatility but also for their potential to offer substantial returns.

Prominent players in the biotech sector include large, well-established companies such as Amgen, Gilead Sciences, and Biogen, which have multiple products on the market and solid research pipelines. Younger companies like Moderna and Regeneron are also notable, especially for their roles in developing treatments and vaccines at an accelerated pace in response to global health crises. These companies represent a mix of stable investments and high-growth potentials within the biotech industry.

While biotech exists in other areas, the majority of the biotech stocks are in the medical and agricultural sectors. Investors might choose individual stocks of companies they believe have potential based on their pipelines or existing products. However, due to the high risk associated with the biotech sector, many opt to diversify their exposure through biotech ETFs or mutual funds, which include a range of companies from startups to established leaders. This strategy can mitigate some of the risks while allowing investors to benefit from the sector's overall growth.

Before investing in biotech stocks, consider the unique risks of this sector, including high development costs, regulatory hurdles, and the binary nature of clinical trial results, which can dramatically affect a company's stock price. Investors should be prepared for volatility and have a tolerance for risk. It is also crucial to research and understand the specific focus areas of biotech companies, as these can vary widely from medical devices and pharmaceuticals to agricultural and environmental biotechnologies. Consulting with a financial advisor who understands the biotech sector can provide valuable insights and guidance tailored to your financial goals.